According to the National Health Profile 2019 data, between 2017 and 2018, there has been an increase of 300 percent in the cases of common cancers like oral, cervical and breast cancer in India. In such a situation, scientists have discovered a T-cell therapy through which all types of cancer can be treated.
Research In London
Scientists have claimed that we can fight all types of cancer by increasing immunity of the body. A team of researchers from Cardiff University in England found that a new type of killer T-cell is also present in the human blood cell. This T-cell is a type of immune cell, which acts as a scanner in the body and eliminates any kind of danger to the body.
From Lung to Cologne, all types of cancer will be treated can be treated by this therapy
When these T-cells were used in the lab, it was found that these cells target the cancer cells in the lungs, skin, blood, colon, breast, bones, prostate, ovarian, kidney and cervical, while the healthy cells of the body Do not harm anyone in any way. T-cell therapy is a new example in the treatment of cancer, and in this therapy, the immune cells are removed, modified and put back into the patient’s blood so that these modified immune cells can eliminate the cancer cells. Currently, the therapy that is most commonly used in the treatment of cancer is called CAR-T which is personalized for every patient but has proved successful in treating only certain types of cancer.
Every patient of cancer will be able to recover from T-cell therapy
If the attack of these T-cell therapies on the cancer cell is also successful, then scientists believe that with one arrow, many hunting systems can be strengthened inside our body. This discovery by the Cardiff University team has been published in the Nature Immunology Medical Journal. Professor Andrew Sewell claims that every T-cell therapy can cure every cancer patient.
New type of T-cell receptor discovered
Cardiff researchers have discovered a new type of T-cells that contain a different type of T-cell receptor (TCR) that identifies most cancers found in humans and eliminates those cancer cells while healthy. There is no harm to the sales. Andrew Seawell, lead author professor of this study, says, “We are hoping that through this new TCR we will find a new way through which we can use this therapy in patients with all types of cancer